Associated with
Tom Cowen
Posted Oct 16, 2023
•
3 min read
The benefits of value creation and value capture for pharma companies
Money and resources go to waste when demand creation doesn't align with market access strategy and execution that doesn't result in placement on critical contracts. Conversely, market access efforts are minimized on drugs with little patient demand. Both are hard slams on the see-saw. How are pharmaceutical manufacturers to manage separated value creation and capture teams? Read on.
More
Ways to Read:
🧃
Juice It
--
The key takeaways that can be read in under a minute
Sign up to unlock
Worth the squeeze
Get access to the condensed version of this piece, and every other article on The Juice, and so much more.
Start a free account on The Juice and we'll send you weekly emails sharing which podcasts, blogs, guides,
etc. are trending with other marketing or sales pros. We call it the Top 5!
Other content from
Conga
Explore more in
Contract Lifecycle Management (CLM)
Featured by ActiveCampaign
